NorthEdge invests in Helios

Katharine Hidalgo
14 January 2021

Tweet
Facebook
LinkedIn
Google plus
Send to

NorthEdge has invested in Helios Medical Communications, a healthcare communications agency.

This is the firm's final investment from NorthEdge Capital Fund II, which closed on £300m in March 2016. It focused on lower-mid-market investments, seeking businesses with enterprise values of £10-100m, with a sweet spot of £20-75m. Typical tickets ranged from £5m to £35m.

Following the transaction, the company plans to expand in both the UK and internationally. The business will work towards launching a new office in Manchester in early 2021.

NorthEdge managing partner Grant Berry and Phil Frame, director and head of north-west England for the firm, will be joining the company's board.

HSBC provided debt facilities for the deal.

Company
Helios, which is based in Cheshire and has a second office in Oxfordshire, works with its pharmaceutical clients to deliver services including medical writing, advisory boards, training and symposia. It employed 60 people as of 2019.

People
NorthEdge – Grant Berry (managing partner); Phil Frame (director, head of north west).

Advisers
Equity – DC Advisory, Richard Pulford, Rob Jones, Antoine Mazerolle, Jimmy Warburton, Radu Ilici (corporate finance); Addleshaw Goddard, Andy Green, George Danczak, Samantha Wright (legal); Candesic, Leonid Shapiro, Hui-Chung Liang (commercial due diligence); BDO, Chris Heatlie (financial due diligence).
Debt – Pinsent Masons (legal).
Company – Alantra, Anthony Harrington, Tom Cowap and Yeboah Mensah-Dika (corporate finance); Squire Patton Boggs, Mark Yeo, Joe Abbott, Lauren Thomas (legal).